114
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Anti-inflammatory property of Kalpaamruthaa on myocardium in type 2 diabetes mellitus induced cardiovascular complication

, &
Pages 119-125 | Received 10 May 2012, Accepted 10 Jul 2012, Published online: 08 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Raja Latha, Palanivelu Shanthi & Panchanadham Sachdanandam. (2014) Kalpaamruthaa Ameliorates Mitochondrial and Metabolic Alterations in Diabetes Mellitus Induced Cardiovascular Damage. Journal of Dietary Supplements 11:4, pages 305-319.
Read now

Articles from other publishers (4)

Sha ZhaoChak Kwong ChengCheng-Lin ZhangYu Huang. (2021) Interplay Between Oxidative Stress, Cyclooxygenases, and Prostanoids in Cardiovascular Diseases. Antioxidants & Redox Signaling 34:10, pages 784-799.
Crossref
Fei Wang, Yanchang Shang, Rong Zhang, Xiangyang Gao & Qiang Zeng. (2018) A SIRT1 agonist reduces cognitive decline in type 2 diabetic rats through antioxidative and anti‑inflammatory mechanisms. Molecular Medicine Reports.
Crossref
Raja LathaPalanivelu ShanthiPanchanadham Sachdanandam. (2013) Kalpaamruthaa modulates oxidative stress in cardiovascular complication associated with type 2 diabetes mellitus through PKC-β/Akt signaling. Canadian Journal of Physiology and Pharmacology 91:11, pages 901-912.
Crossref
Raja LathaPalanivelu ShanthiPanchanadham Sachdanandam. (2013) Kalpaamruthaa ameliorates myocardial and aortic damage in cardiovascular complications associated with type 2 diabetes mellitus. Canadian Journal of Physiology and Pharmacology 91:2, pages 116-123.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.